Sage Therapeutics, Inc. Total Liabilities
Sage Therapeutics, Inc. had Total Liabilities of $54.19 million as of 2025-06-30, per its 10-Q filed 2025-07-30.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2025-07-30
- 2025-06-30: Liabilities $54.19M.
- 2025-03-31: Liabilities $59.82M.
- 2024-12-31: Liabilities $82.13M.
- 2024-09-30: Liabilities $70.60M.
| Period end | Liabilities |
|---|---|
| 2025-06-30 | $54.19M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $59.82M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $82.13M 10-Q · filed 2025-07-30 |
| 2024-09-30 | $70.60M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $69.04M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $61.80M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $82.75M 10-K · filed 2025-02-11 |
| 2023-09-30 | $133.00M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $97.91M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $87.56M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $103.85M 10-K · filed 2024-02-14 |
| 2022-09-30 | $105.95M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $97.14M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $87.20M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $96.26M 10-K · filed 2023-02-16 |
| 2021-09-30 | $91.53M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $85.96M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $77.42M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $86.91M 10-K · filed 2022-02-24 |
| 2020-09-30 | $81.05M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $87.33M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $95.77M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $139.50M 10-K · filed 2021-02-24 |
| 2019-09-30 | $122.66M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $112.67M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $103.38M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $89.73M 10-K · filed 2020-02-27 |
| 2018-09-30 | $58.49M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $51.72M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $41.38M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $54.46M 10-K · filed 2019-02-19 |
| 2017-09-30 | $51.03M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $33.11M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $32.72M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $36.01M 10-K · filed 2018-02-22 |
| 2016-09-30 | $22.56M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $18.42M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $16.01M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $15.32M 10-K · filed 2017-02-24 |
| 2015-09-30 | $10.31M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $11.02M 10-Q · filed 2015-08-12 |
| 2015-03-31 | $8.97M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $7.78M 10-K · filed 2016-02-29 |
| 2014-09-30 | $5.04M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $3.97M 10-Q · filed 2014-08-14 |
| 2013-12-31 | $2.36M 10-K · filed 2015-03-06 |